Project Name ：Azacitidine 

Registration Classification：3.1

Formulations and specifications ：Lyophilized preparations, 50mg, 100mg. 

Indications：For myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).

Original Research Company：Pharmion has developed 

Progress：Has been reported to the State Council , the admissibility number : CXHL1300012; CXHL1300013